EPPICon 2018 SPEAKERS
Aashima Gupta
Global Head – Healthcare Solutions, Google Cloud Platform at Google
Vipin Gopal
Chief Data and Analytics Officer,
Eli Lilly
Jacqueline Law
Global Head, Real World Data Science, Genentech
Ken Carson
Senior Medical Director,
Flatiron Health
Iya Khalil
Co-Founder,
GNS Healthcare
Noga Leviner
Co-Founder and CEO,
PicnicHealth
Jafar Shenasa
VP, Regulatory Affairs,
Proteus Digital Health
Jason Paragas
Director of Innovation,
Lawrence Livermore National Laboratory
Darshan Gandhi
Head of Venture Innovations,
Methodist Health System
Christine Bakan
VP, Head of Software and Bioinformatics,
Roche Molecular Solutions
Sanjay Joshi
Chief of Technology, Healthcare and Life Sciences,
H2O.ai
Raj Harapanahalli
VP, Head of Software Center of Excellence, Diagnostics Information Solutions, Roche
Mamatha Shekar
Director, Biomedical Informatics,
Illumina
Ted Driscoll
Managing Partner,
DigitalDx Ventures
Neil Kumar
CEO and Founder,
BridgeBio
Radhika Iyengar
Founding Partner,
StarChain Ventures
Faz K. Bashi
Investor
Abhijit Thatte
VP, Artificial Intelligence,
Aricent
Serafim Batzoglou
VP, Applied and computational Biology,
Illumina
Gracie Lieberman
Director of Regulatory Policy,
Genentech
Girish Muckai
VP, Business Development & Strategy,
Passage AI
Breakfast And Networking
8:30AM – 9AM
Welcome Address
9AM – 9:15AM
Ashutosh Shastry, President, EPPIC Global
Opening Keynote
9:15AM – 9:45AM
Neil Kumar, CEO and Founder, BridgeBio
Fireside chat: AI and big data in Clinical Development
9.45AM – 10.45AM
- Vipin Gopal, Chief Data and Analytics Officer, Eli Lilly
- Sanjay Joshi, CTO, H20.ai
- Jafar Shenasa, VP, Regulatory Affairs, Proteus Digital Health
- Jason Paragas, Director of Innovation, Lawrence Livermore National Laboratory
- Abhijit Thatte, VP, Artificial Intelligence, Aricent
Break
10:45AM – 11AM
Real world data driven drug development and treatments
11AM – 12:15PM
- Jacqueline Law, Global Head, Real World Data Science, Genentech
- Ken Carson, Senior Medical Director, Flatiron Health
- Iya Khalil, Co-Founder, GNS Healthcare
- Noga Leviner, Co-Founder and CEO, Picnic Health
- Gracie Lieberman, Director of Regulatory Policy, Genentech
Lunch (Networking open)
12:15PM – 1:15PM
Conference Co-Chair Remarks
1:15PM – 1:30PM
Keynote: Genomics and Personalized Medicine
1:30PM – 2PM
Christine (Chris) Bakan, VP, Head of software and bioinformatics at Roche Sequencing Solutions
Digital health and clinical decision support
2PM – 3:15PM
- Darshan Gandhi, Heme/Oncologist, Head of Venture Innovations, Methodist Health System
- Mamatha Shekar, Director, Biomedical Informatics, Illumina
- Aashima Gupta, Global Head – Healthcare Solutions, Google Cloud Platform at Google
- Raj Harapanahalli, VP, Head of Software Center of Excellence, Diagnostics Information Solutions, Roche
Break
3:15PM – 3:30PM
Speed Pitch
3:30PM – 4:30PM
- Ted Driscoll, Managing Partner, DigitalDx Ventures
- Radhika Iyengar, Founding Partner, StarChain Ventures
- Faz K. Bashi, Investor
Closing Keynote
4:30PM – 5PM
- Serafim Batzoglou, VP, Applied and computational Biology, Illumina
Reception 5PM Onwards
“
VC and audience feedback at EPPICon Speed Pitch helped me update the pitch for our company. I was able to connect with lawyers and a CMC consultant, which was very helpful in rounding out the company and helping us close a $12M round later in the year
“
Pradeep Fernandes, Co-founder and CEO, Stealth mode start-up
Pitch your idea to our VC panel at EPPICon 2018!
Who Should Attend
Stakeholders empowering the entire health eco system through technology
Stakeholders
- Innovators
- Researchers
- Enterpreneurs
- Investors
- Payers
- Providers
- Employers
- Regulators
- Policymakers
- Retailers
- Consultants
Health Eco System
- Pharma
- Biotech
- Diagnostics
- Devices
- Clinical decision support
Technology
- Digital health solutions through use of big data
- Analytics
- AI
- Machine learning
EPPICon 2018 SPONSORS
EPPICon 2018 AFFILIATES
EPPICon 2018 CO-CHAIRS
Details
RAVI SRINIVASAN, PhD
Cofounder & CEO, OncoNano Medicine
Dr. Ravi Srinivasan is a seasoned healthcare executive, serial entrepreneur and scientist. He is the Cofounder and CEO of OncoNano Medicine, a clinical stage company developing therapeutic and imaging products targeting pH disorders in diseases such as cancer. He has previously founded StemPar Sciences, an oncology company, and StrataGent Life Sciences, a dermatology company. Ravi is an inventor in over 50 patents and has developed award winning products such as the Microjet “patch-pump” for delivering injectables like insulin painlessly through the skin (Edison award 2010). He has also served in senior executive, product development and manufacturing roles in silicon valley healthcare companies including SEA Medical, Corium, and ForSight V5. Dr. Srinivasan received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.Tech. from IIT Mumbai.
RAVI SRINIVASAN, PhD
CEO, OncoNano
CEO, OncoNano
Details
RAVI SRINIVASAN, PhD
Cofounder & CEO, OncoNano Medicine
Dr. Ravi Srinivasan is a seasoned healthcare executive, serial entrepreneur and scientist. He is the Cofounder and CEO of OncoNano Medicine, a clinical stage company developing therapeutic and imaging products targeting pH disorders in diseases such as cancer. He has previously founded StemPar Sciences, an oncology company, and StrataGent Life Sciences, a dermatology company. Ravi is an inventor in over 50 patents and has developed award winning products such as the Microjet “patch-pump” for delivering injectables like insulin painlessly through the skin (Edison award 2010). He has also served in senior executive, product development and manufacturing roles in silicon valley healthcare companies including SEA Medical, Corium, and ForSight V5. Dr. Srinivasan received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.Tech. from IIT Mumbai.
Details
ASHUTOSH SHASTRY, PhD
President, EPPIC
CTO, Evanostics
Dr. Ashutosh Shastry is the Chief Technology Officer at Evanostics – a medical diagnostics company focused on developing products that re-imagine drug testing and helping resolve the raging opioid crisis in the US. Dr. Shastry has over 15 years of experience developing biosensors and multidisciplinary teams, medical devices and platforms for drug delivery and diagnostics. Utilizing his deep experience with microsystems engineering, Dr. Shastry currently leads the product and technology development for the Evanostics point-of-care detection system. Prior to joining Evanostics, Dr. Shastry served as Vice President R&D at iNDx LifeCare, and as the Director of Engineering at Corium International, Inc. At Corium, he led the technology development and scalable pilot scale manufacturing of a dissolvable microneedles patch that is past Phase IIa. He also led the development of a next generation infusion pump which received an Edison Award in the category of “Science & Medical Device Game Changers.” Earlier, at the University of Washington, Dr. Shastry initiated research on super-hydrophobic surfaces for droplet microfluidics. Dr. Shastry has a PhD in Biomedical Engineering, and MS and BS degrees in Chemical Engineering from the Indian Institute of Technology in Mumbai where he initiated BioMEMS research collaborating with Cancer Research Institute. He has authored numerous publications and has over fifteen patents. He serves on the Industrial Advisory Board for UCLA’s Bioengineering Department, is a member of the National Institute of Health Review Panel for Allergy and Infectious Diseases, and the National Science Foundation SBIR Review Panel for Biomedical Technologies and serves on the Editorial Board of Journal of Robotics and Mechanical Engineering Research.
ASHUTOSH SHASTRY, PhDCTO, Evanostics
Details
ASHUTOSH SHASTRY, PhD
President, EPPIC
CTO, Evanostics
Dr. Ashutosh Shastry is the Chief Technology Officer at Evanostics – a medical diagnostics company focused on developing products that re-imagine drug testing and helping resolve the raging opioid crisis in the US. Dr. Shastry has over 15 years of experience developing biosensors and multidisciplinary teams, medical devices and platforms for drug delivery and diagnostics. Utilizing his deep experience with microsystems engineering, Dr. Shastry currently leads the product and technology development for the Evanostics point-of-care detection system. Prior to joining Evanostics, Dr. Shastry served as Vice President R&D at iNDx LifeCare, and as the Director of Engineering at Corium International, Inc. At Corium, he led the technology development and scalable pilot scale manufacturing of a dissolvable microneedles patch that is past Phase IIa. He also led the development of a next generation infusion pump which received an Edison Award in the category of “Science & Medical Device Game Changers.” Earlier, at the University of Washington, Dr. Shastry initiated research on super-hydrophobic surfaces for droplet microfluidics. Dr. Shastry has a PhD in Biomedical Engineering, and MS and BS degrees in Chemical Engineering from the Indian Institute of Technology in Mumbai where he initiated BioMEMS research collaborating with Cancer Research Institute. He has authored numerous publications and has over fifteen patents. He serves on the Industrial Advisory Board for UCLA’s Bioengineering Department, is a member of the National Institute of Health Review Panel for Allergy and Infectious Diseases, and the National Science Foundation SBIR Review Panel for Biomedical Technologies and serves on the Editorial Board of Journal of Robotics and Mechanical Engineering Research.
Michele Barry, MD, FACP, FASTMH is Professor of Medicine and Tropical Diseases at Stanford University. She is the Director of the Center for Innovation in Global Health and Senior Associate Dean for Global Health. As one of the co-founders of the Yale/Stanford Johnson and Johnson Global Health Scholar Award program, she has sent over 1500 physicians overseas to underserved areas to help strengthen health infrastructure in low resource settings. As a past President of the American Society of Tropical Medicine and Hygiene (ASTMH), she led an educational initiative in tropical medicine and travelers health which culminated in diploma courses in tropical medicine both in the U.S. and overseas, as well as a U.S. certification exam. Dr. Barry is an elected member of the National Academy of Medicine (NAM) and National Academy of Sciences since 2002. She has been selected for Best Doctors in America and currently sits on the NAM Board on Global Health. She is also the 2018 recipient of AMWA’s highest award – the Elizabeth Blackwell medal for creating pathways for women in medicine.
Dr. Anurag Mairal is an Adjunct Professor of Medicine and the Director, Global Outreach Programs at Stanford Byers Center for Biodesign, Stanford University. He is also an Adjunct Professor at Stanford’s Graduate School of Business and a Faculty Fellow and Lead for Technology Innovation and Impact at Center for Innovation in Global Health. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs. He is part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, a graduate-level course offered to engineering, business, and medical students at Stanford University. Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. He serves as the Founding Chair of BME IDEA APAC, a community of medtech innovation programs in Asia Pacific, partnering closely with the industry and academia in the region. He is also an Honorary Professor at University of Cape Town, South Africa. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry. 
Amy Lin is CII’s Acting Deputy Director and Market Access Team Lead, where she focuses on market-based strategies like strategic planning, market shaping and innovative financing to accelerate adoption of high-priority health interventions. Previously, Amy was based in Mumbai with Monitor Inclusive Markets, where she developed social enterprise models that provide clean drinking water in slums. Prior to this role, she served as the HIV/AIDS Program Director for the Clinton Health Access Initiative (CHAI) in Liberia. Before CHAI, Amy was at the World Bank’s Development Marketplace, which funds new approaches to serving the poor.
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as Faculty Chair for Medicine at 
Mintu P. Turakhia, MD MAS
Praveen Raja, PhD, is Chief Operating Officer at PATH, a major global health NGO. In this role, he is focused on bringing cohesion to the operations functions at PATH to more effectively and efficiently support PATH’s mission of accelerating health equity across the globe. In addition, Dr. Raja also serves as an institutional officer for the organization to guide global business development strategy.
Steve became PATH’s president and CEO in 2012. Before joining PATH, he was director of Social Innovation at McKinsey & Company, CEO of the global digital media firm Corbis, and interim director of the Infectious Disease Research Institute. Prior to that, he practiced law at the international law firm K&L Gates. He has also worked extensively on refugee programs and policies, as well as Chinese politics and law.